ImmunityBio, Inc. (IBRX)
7.20
+0.22
(+3.15%)
USD |
NASDAQ |
Jun 11, 16:00
7.15
-0.05
(-0.69%)
After-Hours: 20:00
ImmunityBio Debt to Equity Ratio : -1.293 for March 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2026 | -1.293 |
| December 31, 2025 | -1.688 |
| September 30, 2025 | -1.643 |
| June 30, 2025 | -1.476 |
| March 31, 2025 | -1.391 |
| December 31, 2024 | -1.615 |
| September 30, 2024 | -1.367 |
| June 30, 2024 | -1.430 |
| March 31, 2024 | -1.294 |
| December 31, 2023 | -1.505 |
| September 30, 2023 | -1.748 |
| June 30, 2023 | -1.276 |
| March 31, 2023 | -1.449 |
| December 31, 2022 | -1.622 |
| September 30, 2022 | -1.674 |
| June 30, 2022 | -1.493 |
| March 31, 2022 | -1.833 |
| December 31, 2021 | -2.666 |
| September 30, 2021 | -1.831 |
| June 30, 2021 | -2.105 |
| March 31, 2021 | -1.720 |
| December 31, 2020 | 0.1426 |
| September 30, 2020 | 0.1269 |
| Date | Value |
|---|---|
| June 30, 2020 | 0.074 |
| March 31, 2020 | 0.1337 |
| December 31, 2019 | 0.123 |
| September 30, 2019 | 0.1174 |
| June 30, 2019 | 0.0991 |
| March 31, 2019 | 0.094 |
| December 31, 2018 | 0.0473 |
| September 30, 2018 | 0.0451 |
| June 30, 2018 | 0.0377 |
| March 31, 2018 | 0.0351 |
| December 31, 2017 | 0.0332 |
| September 30, 2017 | 0.0316 |
| June 30, 2017 | 0.0884 |
| March 31, 2017 | 0.0287 |
| December 31, 2016 | 0.028 |
| September 30, 2016 | 0.0248 |
| June 30, 2016 | 0.0074 |
| March 31, 2016 | 0.0071 |
| December 31, 2015 | 0.0069 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Sana Biotechnology, Inc. | 0.6317 |
| Erasca, Inc. | 0.1168 |
| Arrowhead Pharmaceuticals, Inc. | 2.237 |
| Denali Therapeutics, Inc. | 0.0432 |
| Cogent Biosciences, Inc. | 0.3927 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 646.64M |
| Total Liabilities (Quarterly) | 1.516B |
| Shareholders Equity (Quarterly) | -870.01M |
| Current Ratio | 6.666 |
| Net Debt Paydown Yield | -0.83% |